Interferon beta-1b for COVID-19.

Authors	Sarah Shalhoub
Journal	Lancet (London, England) (Lancet) Vol. 395 Issue 10238 Pg. 1670-1671 (05 30 2020) ISSN: 1474-547X [Electronic] England
PMID	32401712 (Publication Type: Journal Article, Comment)
Chemical References	Adjuvants, Immunologic Interferon beta-1b Lopinavir Ribavirin Ritonavir
Topics	Adjuvants, Immunologic Betacoronavirus COVID-19 Coronavirus Infections (drug therapy) Humans Interferon beta-1b Lopinavir Multiple Sclerosis Pandemics Pneumonia, Viral Ribavirin Ritonavir SARS-CoV-2 COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!